Effect of lipophilicity on in vivo iontophoretic delivery. II. Beta-blockers.
The objective of this study was to investigate the relationship between drug lipophilicity and the transdermal absorption processes in the iontophoretic delivery in vivo. Anodal iontophoresis of beta-blockers as model drugs having different lipophilicity (atenolol, pindolol, metoprolol, acebutolol, oxprenolol and propranolol) was performed with rats (electrical current, 0.625 mA/cm2; application period, 90 min), and the drug concentrations in skin, cutaneous vein and systemic vein were determined. Increasing the lipophilicity of beta-blockers caused a greater absorption into the skin. Exceptionally, it was found that pindolol had high skin absorption, irrespective of its hydrophilic nature. Further, the drug transfer rate from skin to cutaneous vein (R(SC)) was evaluated from the arterio-venous plasma concentration difference of drug in the skin. Normalized R(SC) by skin concentration showed a negative correlation with the logarithm of n-octanol/buffer partition coefficient (Log P, pH 7.4), suggesting the partitioning between stratum corneum and viable epidermis was a primary process to determine the transfer properties of beta-blockers to local blood circulation. Pindolol exhibited both high skin absorption and high transfer from skin to cutaneous vein. These characteristics of pindolol could be explained by the chemical structure, molecular size and hydrophilicity. These findings for pindolol should be valuable for the optimal design of drug candidates for iontophoretic transdermal delivery.
Tashiro
Y
Y
Drug Formulation Research Laboratories, Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co.. Ltd., Sunto-gun, Shizuoka, Japan. yoshikazu.tashiro@kyowa.co.jp
Sami
M
M
Shichibe
S
S
Kato
Y
Y
Hayakawa
E
E
Itoh
K
K
D000319:Adrenergic beta-Antagonists / Q000097:blood / Q000737:chemistry* / Q000493:pharmacokinetics; D000818:Animals; D007478:Iontophoresis; D008055:Lipids / Q000737:chemistry*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012869:Skin Absorption
D000319:Adrenergic beta-Antagonists; D008055:Lipids